Rebalix
Logo LGIMLGIM · sheet of 4 September 2026
ETF sheet · official issuer and register data

L&G Gold Mining UCITS ETF

AUCO · IE00B3CNHG25 · class USD Acc. · USD · domicile Ireland
Equity · Global · Gold & silver minersSFDR art. 6
Index tracked: DAXglobal® Gold Miners Net TR USD
TER
0.60%+ trans. 0.08%
Fund size
549 m EUR
Tracking difference
−0.94%3-year avg
🇮🇹 tax rate
white list not published
Replication
Physical (full replication)
Income
Accumulating
Launch 6 Nov 2008 · costs from the KID as of 2 Sept 2026 · 0 securities held · 10 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 5 Aug 2026
The investment objective of the Fund is to provide exposure to international gold mining companies that are actively engaged in the mining and production of gold ore. The Fund is passively managed and aims to track the performance of the Global Gold Miners Index (the “Index”), before the deduction of fees and expenses. The Index is designed to provide exposure to global companies that are actively engaged in gold mining and related activities, in accordance with its methodology. The Fund seeks to achieve its investment objective by investing primarily…

Performance since series start (in euro) — base 100

29 Jul 201631 Jul 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
2017201920212023202544255296
High 442 (26 Feb 2026) · low 55 (11 Sept 2018) · last 296. Past performance is not indicative of future results.

Returns in euro

1 year+46.5%
3 years+182.5%
5 years+175.4%
10 years+196.4%
Since series start+196.4%

Risk · 1 / 3 / 5 years

Volatility (ann.)46.04%36.69%34.50%
Max drawdown−39.07%−39.07%−48.70%
Sharpe1.191.440.87
Sortino1.702.121.28
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · AUCO · IE00B3CNHG251
RebalixAUCO · IE00B3CNHG25 · sheet of 4 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+180.86%+182.44%−1.57%
2024+18.28%+18.92%−0.64%
2023+16.28%+16.90%−0.62%
2022−15.32%−15.45%+0.12%
2021−9.50%−9.17%−0.33%

Holdings

Portfolio as declared by the issuer · 30 Jun 2026 · 0 securities · top-10 weight = 67.8%
Top holdingsWeight
Newmont15.8%
Agnico-Eagle Mines10.8%
AngloGold Ashanti9.3%
Gold Fields6.9%
Kinross Gold6.2%
Northern Star5.8%
Harmony Gold5.1%
B2gold3.0%
Evolution Mining2.5%
IAMGOLD2.4%
Countries (% of fund)
Canada41.4%Sudafrica21.7%Australia18.1%Stati Uniti17.7%Regno Unito1.0%
Sectors (% of fund)
Materiali di base100.0%

Listing venues

ESMA register (FIRDS) and official exchange lists
AUCO · Borsa Italiana (ETFplus), Euronext Amsterdam
ETLX · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 15 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · fundcentres.landg.com/srp/documents-id/2894b113-f7c5-44fd-8d45-c5963c5
Factsheet · fundcentres.landg.com/srp/documents-id/abf72dfa-fb48-4847-a752-6064074
Prospectus · fundcentres.landg.com/srp/lit/7qeQjP/Prospectus_Legal-General-UCITS-ET
The live sheet, always up to date
rebalix.com/en/etf/IE00B3CNHG25
Series, distributions, holdings and documents refresh daily.
Sheet produced on 4 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · AUCO · IE00B3CNHG252